CardioSignal offers a digital cardiac biomarker for self-monitoring, remote care, and point-of-care diagnostics. CardioSignal's patented technology enables a digital cardiac biomarker for several major heart diseases, representing a breakthrough in the fight against heart disease, the world's most expensive and lethal disease.CardioSignal's digital cardiac biomarkers can replace invasive and expensive standard care technologies, allowing for faster and less expensive care.

Apps

Biotechnology

Health Care

CardioSignal

CardioSignal's headquarters in Turku, Finland

The Palo Alto office focuses on regulatory compliance and strategic oversight in the biotechnology and life sciences sectors.

Palo Alto

Juuso Blomster

Tuomas Valtonen

Ilkka Korhonen

Kristiina Santalahti

The Development Team at CardioSignal is responsible for designing and building innovative software solutions that enhance the functionality and user experience of the digital cardiac biomarker platform. Comprising experts in Flutter development, algorithm engineering, data science, and backend systems, the team collaborates to create reliable, efficient, and user-friendly applications that support remote care and diagnostics. Additionally, they analyze data trends to continuously improve the technology and ensure it meets clinical and user needs.

Development Team

This department manages relationships with the board of directors and investors.

Board Relations

The Engineering and Quality Assurance team at CardioSignal is responsible for the design, development, and rigorous testing of cutting-edge digital cardiac biomarker technologies. This team ensures the reliability and accuracy of these innovations through meticulous quality control processes, safeguarding patient safety and compliance with healthcare regulations. By collaborating closely with other departments, they drive continuous improvement and maintain high standards in both product performance and user experience.

Engineering and Quality Assurance

The Leadership Team at CardioSignal is responsible for setting the strategic direction and overarching vision of the company. Comprising the Chief Executive Officer, Chief Scientific Officer, Chief Quality Officer, and Chief Operating Officer, this team collaborates to drive innovation in digital cardiac biomarker technology, ensure regulatory compliance and quality assurance, and optimize operational efficiencies, ultimately aiming to enhance patient care and position CardioSignal as a leader in the fight against heart disease.

CardioSignal

Org chart

Teams

Development Team

Board Relations

Engineering and Quality Assurance

Leadership Team

Offices

CardioSignal

Org chart

Teams

Development Team

Board Relations

Engineering and Quality Assurance

Leadership Team

Offices

Related companies